FIXORINOX 50 micrograms/dose, suspension for spraying nasal 120 doses
Active ingredients: Fluticasone propionate
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for spraying120 dosesnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FIXORINOX 50 microgrammes/dose, suspension pour pulvérisation nasale
- Pharmaceutical form
- suspension pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) pulvérisateur(s) en verre brun de 120 dose(s) avec pompe(s) doseuse(s)
- Marketing authorisation holder
- THERABEL PHARMA (LUXEMBOURG)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Jan 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60564219CIP73975831CIP133400939758312Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPIONATE DE FLUTICASONEsuspension | 50 microgrammes · une dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.